Hello, everyone, and welcome to the working week. And this will be a different kind of week around the Pharmalot corporate campus, where our site is undergoing a redesign, which is expected to debut later today. In other words, there will be a few visual changes, but nothing terribly different. However, if you have questions, please feel free to write us pharmalot@gmail.com. Meanwhile, the time has come to get started. As always, here are some tidbits to help you along. Hope your day goes well and stay in touch...
AstraZeneca Settles Patent Row With Generic Drugmakers (Reuters)
EMA'sCHMP Backs Biogen and Sanofi MS Pills (Pharma Times)
FDA Alerts On Epilepsy Meds Miss Some Neurologists (MedPage Today)
Drugmakers Want More Info On Clinical Trial Strategies Guidance (Outsourcing Pharma)
Statins Tied To Lower Liver Cancer Risk With Hepatitis C (Reuters)
Sanofi Seeks More Venture Capital Deals (Bloomberg News)
EDITOR'S NOTE: Please check this post for additional stories during the day